[
  {
    "ts": null,
    "headline": "GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues",
    "summary": "Globus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.",
    "url": "https://finnhub.io/api/news?id=cb50fdf6fd2aa0652c660a3a7c8e5cffa86ec2ae1623be60115d7b86cfc2ef9f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736522640,
      "headline": "GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues",
      "id": 132367337,
      "image": "https://media.zenfs.com/en/zacks.com/228e67967b066e7a755ae3614be720e1",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Globus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.",
      "url": "https://finnhub.io/api/news?id=cb50fdf6fd2aa0652c660a3a7c8e5cffa86ec2ae1623be60115d7b86cfc2ef9f"
    }
  },
  {
    "ts": null,
    "headline": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
    "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
    "url": "https://finnhub.io/api/news?id=66a78e50653e2304d1d91316003d399708c728e8a5b824ceb9fdd6a4275e09ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736517612,
      "headline": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
      "id": 132365065,
      "image": "https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
      "url": "https://finnhub.io/api/news?id=66a78e50653e2304d1d91316003d399708c728e8a5b824ceb9fdd6a4275e09ee"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Retain HealthEquity Stock in Your Portfolio Now",
    "summary": "HQY's sustained strength in HSAs raises optimism about the stock.",
    "url": "https://finnhub.io/api/news?id=ee73aff29e176a4fe2089c5840cfa297d6daa722916fd97f0fbd452687bb8b76",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736512260,
      "headline": "Here's Why You Should Retain HealthEquity Stock in Your Portfolio Now",
      "id": 132365197,
      "image": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "HQY's sustained strength in HSAs raises optimism about the stock.",
      "url": "https://finnhub.io/api/news?id=ee73aff29e176a4fe2089c5840cfa297d6daa722916fd97f0fbd452687bb8b76"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain The Cooper Companies Stock in Your Portfolio Now",
    "summary": "COO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise in selling, general and administrative expenses is concerning.",
    "url": "https://finnhub.io/api/news?id=28cceae7af6411c7d6a113b67743e6210698ac29e546499a676dbd163d78cb8b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736511360,
      "headline": "Reasons to Retain The Cooper Companies Stock in Your Portfolio Now",
      "id": 132365198,
      "image": "https://media.zenfs.com/en/zacks.com/529a2bf6a4c772f942409efa3808349b",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "COO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise in selling, general and administrative expenses is concerning.",
      "url": "https://finnhub.io/api/news?id=28cceae7af6411c7d6a113b67743e6210698ac29e546499a676dbd163d78cb8b"
    }
  },
  {
    "ts": null,
    "headline": "MYGN Stock Gains Following Collaboration With Hannah Storm",
    "summary": "Myriad Genetics enters into an agreement with Hannah Storm, who will be the Myriad Genetics Breast Cancer Risk Assessment Program ambassador.",
    "url": "https://finnhub.io/api/news?id=47b48108de66e5005baff20d8db2bfe13b4b968b9d92aa4eae9b318a7d760bf8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736511300,
      "headline": "MYGN Stock Gains Following Collaboration With Hannah Storm",
      "id": 132365199,
      "image": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Myriad Genetics enters into an agreement with Hannah Storm, who will be the Myriad Genetics Breast Cancer Risk Assessment Program ambassador.",
      "url": "https://finnhub.io/api/news?id=47b48108de66e5005baff20d8db2bfe13b4b968b9d92aa4eae9b318a7d760bf8"
    }
  }
]